MyMD Pharmaceuticals

+$0.07 (+2.77%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYMD and other ETFs, options, and stocks.

About MYMD

MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. It focuses on developing and commercializing the MyMD-1 and SUPERA-CBD therapeutic platforms.

CEO
Christopher C. Chapman, Jr., MD
Employees
—
Headquarters
Baltimore, Maryland
Founded
1989

MYMD Key Statistics

Market cap
98.95M
Price-Earnings ratio
—
Dividend yield
—
Average volume
93.56K
High today
$2.97
Low today
$2.47
Open price
$2.55
Volume
61.30K
52 Week high
$9.95
52 Week low
$1.88

MYMD Earnings

-$0.50
-$0.33
-$0.17
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.11 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure